InvestorsHub Logo
Followers 61
Posts 3376
Boards Moderated 1
Alias Born 12/26/2012

Re: Solantey post# 50616

Sunday, 01/27/2013 1:27:23 PM

Sunday, January 27, 2013 1:27:23 PM

Post# of 130503
AMBS has closed a $10M Equity Funding Facility from before,, they can still draw from this if they want to... since they have hardly needed it most of it is unused. 36 Months means they have access to it until OCT. 2014

AMBS will have plenty cash soon, its inevitable

SUNNYVALE, CA--(Marketwire - Oct 13, 2011) - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class, disease-modifying therapeutic protein that addresses an underlying form of cell death known as apoptosis, announced today that it has closed a $10M Equity Funding Facility with Centurion Private Equity, LLC ("Centurion"). The Company will have the ability to draw down on this facility over the course of the next 36 months in tranches of up $750,000, subject to certain conditions and limitations described in the agreement, including limitations based upon the price and trading volume of the Company's common stock, upon the successful registration of the common shares underlying the facility with the Securities & Exchange Commission.

http://www.marketwire.com/press-release/amarantus-biosciences-announces-close-10m-equity-funding-facility-with-centurion-private-otcbb-ambs-1572738.htm